3min chapter

The MATTER Health Podcast cover image

Tales from the Trenches™ with Sheila Mikhail, Co-founder and CEO of AskBio

The MATTER Health Podcast

CHAPTER

Gene Therapy - One Time Treatments

In the early days of gene therapy, there was a concern that payers and insurance companies wouldn't pay high enough of a price to offset the revenue streams from a more recurring treatment. The drug for SMA by VEX's now Novartis got approved. These drugs have high prices associated with them, but it's necessary because without those higher prices, I don't think you would see as much money and innovation in the sector.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode